Predictive Low Glucose Management (PLGM) Trial : Comparing insulin pump therapy with predictive low glucose suspend feature versus standard sensor augmented pump therapy in patients with type 1 diabetes.

Phase 2

Completed

• Conditions: Type 1 diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12614000510640
• Lead Sponsor: Professor Timothy Jones

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-05-13
• Study Completion: 2016-11-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 169

Inclusion Criteria

1) Age: 8-20yrs at Princess Margaret Hospital, Perth and John Hunter Children's Hospital, Newcastle; Age 8-18yrs at Westmead Children's Hospital, Sydney, Women and Children's Hospital,Adelaide and RCH, Melbourne
2) T1DM for >1 year
3) On insulin pump therapy for >6 months
4) HbA1c < 10.0%

Exclusion Criteria

1) Medical conditions predisposing to hypoglycaemia other than diabetes
2) Oral glycaemic medications
3) Inability or refusal to meet protocol requirements
4 ) Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified